Susan M. Mendrysa

Basic Medical Sciences Purdue University, West Lafayette, IN, United States 
Cell Biology, Oncology, Human Development
"Susan Mendrysa"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kwon DH, Eom GH, Ko JH, et al. (2016) MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification. Nature Communications. 7: 10492
Wang G, Fulkerson CM, Malek R, et al. (2012) Mutations in Lyar and p53 are synergistically lethal in female mice. Birth Defects Research. Part a, Clinical and Molecular Teratology. 94: 729-37
Ghassemifar S, Mendrysa SM. (2012) MDM2 antagonism by nutlin-3 induces death in human medulloblastoma cells. Neuroscience Letters. 513: 106-10
McGowan KA, Pang WW, Bhardwaj R, et al. (2011) Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood. 118: 3622-33
Mendrysa SM, Ghassemifar S, Malek R. (2011) p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer. Genes & Cancer. 2: 431-42
Malek R, Matta J, Taylor N, et al. (2011) The p53 inhibitor MDM2 facilitates Sonic hedgehog-mediated tumorigenesis and influences cerebellar foliation Plos One. 6
Mendrysa SM, Akagi K, Roayaei J, et al. (2010) An Integrated Genetic-Genomic Approach for the Identification of Novel Cancer Loci in Mice Sensitized to c-Myc-Induced Apoptosis. Genes & Cancer. 1: 465-479
Laurie NA, Donovan SL, Shih CS, et al. (2006) Inactivation of the p53 pathway in retinoblastoma. Nature. 444: 61-6
Mendrysa SM, Perry ME. (2006) Tumor suppression by p53 without accelerated aging: Just enough of a good thing? Cell Cycle. 5: 714-717
Mendrysa SM, O'Leary KA, McElwee MK, et al. (2006) Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes & Development. 20: 16-21
See more...